Content about Isis

August 13, 2013

Schick Xtreme3, an Energizer Personal Care brand, announced the launch of "Camino Al Exito," or Journey to Success, a national Hispanic campaign that offers one boxer and one dancer the chance to make their dreams a reality.

SHELTON, Conn. — Schick Xtreme3, an Energizer Personal Care brand, announced today the launch of "Camino Al Exito," or Journey to Success, a national Hispanic campaign that offers one boxer and one dancer the chance to make their dreams a reality.

Six individuals — three boxers: Ramiro Angel Huerta, Jay Rodriguez and Wesley Ferrer, and three dancers: Isis Avalos, Gabriela Soto and Kathy Reyes — will have the chance to tell their stories and compete for a boost on their quests to achieve lifelong goals with help from Schick Xtreme3.

January 5, 2012

Biogen Idec and Isis Pharmaceuticals will work together on a drug invented by Isis for spinal muscular atrophy, the two companies said.

WESTON, Mass. — Biogen Idec and Isis Pharmaceuticals will work together on a drug invented by Isis for spinal muscular atrophy, the two companies said.

According to the companies, SMA is the most common genetic cause of infant mortality and causes muscle atrophy and weakness, occurring in 1-in-10,000 births. While children with the condition appear normal at birth, symptoms can develop within a few months and significantly shorten their lifespan. The drug, ISIS-SMNRx, is designed to compensate for the underlying genetic defect that causes SMA.

August 5, 2010

Biotech company Genzyme and Isis Pharmaceuticals have finished late-stage clinical trials of a cholesterol-lowering drug,...